Cargando…
A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression
Alzheimer’s disease (AD), the most common form of senile dementia, is poised to place an even greater societal and healthcare burden as the population ages. With few treatment options for the symptomatic relief of the disease and its unknown etiopathology, more research into AD is urgently needed. P...
Autores principales: | Pilozzi, Alexander, Foster, Simmie, Mischoulon, David, Fava, Maurizio, Huang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419627/ https://www.ncbi.nlm.nih.gov/pubmed/37569888 http://dx.doi.org/10.3390/ijms241512513 |
Ejemplares similares
-
The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020) -
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021) -
Overcoming Alzheimer’s Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies
por: Pilozzi, Alexander, et al.
Publicado: (2020) -
Designing Socially Assistive Robots for Alzheimer’s Disease and Related Dementia Patients and Their Caregivers: Where We Are and Where We Are Headed
por: Koutentakis, Dimitrios, et al.
Publicado: (2020) -
Network Medicine Approach for Analysis of Alzheimer’s Disease Gene Expression Data
por: Cohen, David, et al.
Publicado: (2020)